This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Asia Renal Care Limited
Asia Renal Care Limited, headquartered in Singapore (SG), is a leading provider in the renal care industry, specialising in dialysis services and related healthcare solutions. Founded in 2005, the company has established a strong presence across Asia, with operations in several key regions, including Malaysia and Indonesia. Asia Renal Care Limited is dedicated to delivering high-quality, patient-centred care through its state-of-the-art dialysis facilities and innovative treatment options. The company’s commitment to excellence is reflected in its advanced technology and skilled healthcare professionals, setting it apart in a competitive market. With a focus on improving patient outcomes, Asia Renal Care Limited has achieved significant milestones, positioning itself as a trusted name in renal healthcare. Its reputation for reliability and quality service continues to drive its growth and expansion across the region.
DitchCarbon Score
How does Asia Renal Care Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Asia Renal Care Limited's score of 36 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Asia Renal Care Limited, headquartered in Singapore (SG), currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Fresenius Medical Care AG, which influences its climate commitments and emissions reporting. As part of its corporate family relationship, Asia Renal Care Limited inherits climate initiatives and targets from Fresenius Medical Care AG. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are aimed at reducing greenhouse gas emissions across their operations. While specific reduction targets or achievements for Asia Renal Care Limited are not detailed, the overarching goals set by Fresenius Medical Care AG guide the company's climate strategy. These initiatives reflect a commitment to sustainability and reducing environmental impact within the healthcare sector. In summary, while Asia Renal Care Limited does not provide specific emissions data or reduction targets, it aligns with the climate commitments of its parent company, Fresenius Medical Care AG, to foster a more sustainable future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 557,200,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Asia Renal Care Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
